|
HECTD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
4.11000000033468E-07 |
| Normal-vs-Stage3 |
1.77635683940025E-15 |
| Normal-vs-Stage4 |
1.82076576038526E-14 |
| Stage1-vs-Stage2 |
1.406980E-01 |
| Stage1-vs-Stage3 |
1.775200E-01 |
| Stage1-vs-Stage4 |
1.919620E-02 |
| Stage2-vs-Stage3 |
3.559500E-02 |
| Stage2-vs-Stage4 |
7.044500E-03 |
| Stage3-vs-Stage4 |
3.374600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.8771199999934E-05 |
| Normal-vs-Asian |
2.33320029963124E-10 |
| Caucasian-vs-AfricanAmerican |
2.285600E-01 |
| Caucasian-vs-Asian |
7.922400E-01 |
| AfricanAmerican-vs-Asian |
3.775600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.17141884870398E-13 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.277600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
6.66133814775094E-16 |
| Normal-vs-Age(61-80Yrs) |
2.37565522809291E-12 |
| Normal-vs-Age(81-100Yrs) |
8.13970000000941E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.011400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.952000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.801800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.660400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.708800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.135400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.737900E-03 |
| Classical-VS-Follicular |
9.486800E-01 |
| Classical-VS-Other |
3.366200E-01 |
| Classical-VS-Normal |
4.15919521046249E-11 |
| Tall-VS-Follicular |
2.704100E-02 |
| Tall-VS-Other |
8.622000E-01 |
| Tall-VS-Normal |
4.19442258703384E-13 |
| Follicular-VS-Other |
4.011000E-01 |
| Follicular-VS-Normal |
4.14239753609991E-11 |
| Other-VS-Normal |
3.381200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
1.65756297576536E-13 |
| N0-vs-N1 |
7.898300E-02 |
|
|
